[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5646 Introduced in House (IH)]

<DOC>






115th CONGRESS
  2d Session
                                H. R. 5646

  To require the Secretary of Health and Human Services to submit to 
 Congress a report on opioids prescribing practices for pregnant women.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 27, 2018

  Mr. Curtis (for himself, Mr. Bishop of Utah, Mr. Stewart, Mr. Diaz-
    Balart, and Mrs. Love) introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
  To require the Secretary of Health and Human Services to submit to 
 Congress a report on opioids prescribing practices for pregnant women.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting against Opioid 
Prescription-abuse during Prenatal Year Study Act'' or the ``POPPY 
Study Act''.

SEC. 2. REPORT ON OPIOIDS PRESCRIBING PRACTICES FOR PREGNANT WOMEN.

    (a) In General.--Not later than 180 days after the date of the 
enactment of this Act, the Secretary of Health and Human Services, in 
coordination with the Centers for Disease Control and Prevention, the 
National Institutes of Health, and the Substance Abuse and Mental 
Health Services Administration shall develop and submit to the Congress 
a report--
            (1) on opioids prescribing practices for pregnant women and 
        recommendations for such practices;
            (2) that provides recommendations for identifying and 
        reducing opioids misuse during pregnancy;
            (3) on prescription opioid misuse during pregnancy in urban 
        and rural areas;
            (4) on prescription opioid use during pregnancy for the 
        purpose of medication-assisted treatment in urban and rural 
        areas;
            (5) evaluating current utilization of non-opiate pain 
        management practices in place of prescription opioids during 
        pregnancy;
            (6) providing guidelines encouraging the use of non-opioid 
        pain management practices during pregnancy when safe and 
        effective; and
            (7) that provides recommendations for increasing public 
        awareness and education of opioid use disorder in pregnancy, 
        including available treatment resources in urban and rural 
        areas.
    (b) No Additional Funds.--No additional funds are authorized to be 
appropriated for purposes of carrying out subsection (a).
                                 <all>